Numinus Wellness, Inc. (NUMIF)
0.0216
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Numinus Wellness Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| May 31, 2025 | -1.495 |
| February 28, 2025 | -3.113 |
| November 30, 2024 | -4.749 |
| May 31, 2024 | 1.528 |
| February 29, 2024 | 0.6328 |
| November 30, 2023 | 0.6728 |
| August 31, 2023 | 0.5125 |
| May 31, 2023 | 0.3396 |
| February 28, 2023 | 0.2751 |
| November 30, 2022 | 0.218 |
| August 31, 2022 | 0.1905 |
| May 31, 2022 | 0.1187 |
| February 28, 2022 | 0.1055 |
| November 30, 2021 | 0.1376 |
| August 31, 2021 | 0.0264 |
| May 31, 2021 | 0.0212 |
| February 28, 2021 | 0.0205 |
| November 30, 2020 | 0.1087 |
| August 31, 2020 | 0.1506 |
| May 31, 2020 | 0.1009 |
| January 31, 2020 | 0.00 |
| October 31, 2019 | 0.00 |
| July 31, 2019 | 0.00 |
| April 30, 2019 | 0.00 |
| January 31, 2019 | 0.00 |
| Date | Value |
|---|---|
| October 31, 2018 | 0.00 |
| July 31, 2018 | 0.00 |
| April 30, 2018 | 0.00 |
| January 31, 2018 | 0.00 |
| October 31, 2017 | 0.00 |
| July 31, 2017 | 0.00 |
| April 30, 2017 | 0.00 |
| January 31, 2017 | 0.00 |
| October 31, 2016 | 0.00 |
| July 31, 2016 | 0.00 |
| April 30, 2016 | 0.00 |
| January 31, 2016 | 0.00 |
| October 31, 2015 | 0.00 |
| July 31, 2015 | 0.00 |
| April 30, 2015 | 0.0189 |
| January 31, 2015 | 0.0237 |
| October 31, 2014 | 0.0226 |
| July 31, 2014 | 0.0189 |
| April 30, 2014 | 0.1301 |
| January 31, 2014 | 0.00 |
| October 31, 2013 | 0.00 |
| July 31, 2013 | 0.00 |
| April 30, 2013 | 0.00 |
| January 31, 2013 | 0.00 |
| October 31, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Cocrystal Pharma, Inc. | 0.346 |
| Edesa Biotech, Inc. | 0.00 |
| CNBX Pharmaceuticals, Inc. | -0.46 |
| GB Sciences, Inc. | -- |
| ProMIS Neurosciences, Inc. | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.118M |
| Total Liabilities (Quarterly) | 4.249M |
| Shareholders Equity (Quarterly) | -1.131M |